Key result
Multi-ancestry genetic analysis identifies novel SLC2A9 locus and optimizes polygenic prediction of LDL-C levels.
Observational (n=13,701)
Yes
Answers are grounded in this paper and cite their sources.
Identified a novel genetic locus (SLC2A9) associated with LDL-C levels and demonstrated the utility of multi-ancestry polygenic scores in a Middle Eastern population.
The genetic determinants of low-density lipoprotein cholesterol (LDL-C) levels in blood have been predominantly explored in European populations and remain poorly understood in Middle Eastern populations. We investigated the genetic architecture of LDL-C variation in Qatar by conducting a genome-wide association study (GWAS) on serum LDL-C levels using whole genome sequencing data of 13,701 individuals (discovery; n = 5,939, replication; n = 7,762) from the population-based Qatar Biobank (QBB) cohort. We replicated 168 previously reported loci from the largest LDL-C GWAS by the Global Lipids Genetics Consortium (GLGC), with high correlation in allele frequencies ( R 2 = 0.77) and moderate correlation in effect sizes (Beta; R 2 = 0.53). We also performed a multi-ancestry meta-analysis with the GLGC study using MR-MEGA (Meta-Regression of Multi-Ethnic Genetic Association) and identified one novel LDL-C-associated locus; rs10939663 ( SLC2A9 ; genomic control-corrected P = 1.25 × 10 −8 ). Lastly, we developed Qatari-specific polygenic score (PGS) panels and tested their performance against PGS derived from other ancestries. The multi-ancestry-derived PGS (PGS000888) performed best at predicting LDL-C levels, whilst the Qatari-derived PGS showed comparable performance. Overall, we report a novel gene associated with LDL-C levels, which may be explored further to decipher its potential role in the etiopathogenesis of cardiovascular diseases. Our findings also highlight the importance of population-based genetics in developing PGS for clinical utilization.
No takes yet. Share an insight, caveat, or question.
Umlai et al. (2025) conducted an observational in LDL-C levels (n=13,701). Genetic variants and polygenic scores was evaluated on LDL-C-associated loci (p=1.25 × 10^-8). A multi-ancestry meta-analysis identified a novel LDL-C-associated locus, rs10939663 (SLC2A9; P = 1.25 × 10^-8), and showed multi-ancestry polygenic scores best predicted LDL-C levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: